Clinical Trial: A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07572240) titled 'A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals' on April 29.

Brief Summary: The goal of this clinical trial is to learn about the effects of AP-Brain collagen peptide on attention, focus, and memory in adults who are stressed but otherwise healthy.

The main questions it aims to answer are:

* How does AP-Brain affect a participant's attention, focus, stress, and memory?

* Is there a difference in the effects between a higher dose and a lower dose?

* What are the side effects,...